This morning Biofourmis, maker of an artificial intelligence-enabled monitoring and decision support platform, announced its plans to acquire Zürich, Switzerland-based wearable biosensor company Biovotion. The terms of the deal are not disclosed; however, we do know the deal is made up of a combination of cash and equity.
The acquisition will include Biovotion’s clinical grade-wearable...
Fitbit’s year-over-year device sales flatlined in Q3 2019, which combined with lower sales tag prices drove a decline in revenue, according to the wearables maker’s latest quarterly earnings.
The reporting — which was bereft of an investor’s call, Q&A and any forward-looking statements due to the company’s pending acquisition — is the latest look at a wearables business Google apparently...
After a month of rumors, this morning Google and Fitbit announced that the former has officially purchased the wearable giant for roughly $2.1 billion, or $7.35 per share, in cash.
Fitbit stressed that its devices will remain platform-agnostic across the Android and iOS ecosystems. Still, a blog post from Google discussing the acquisition made it clear that we can also expect to see some Google...
Alphabet serious about health wearables? Alphabet has reportedly put in an unspecified offer to buy out Fitbit, according to anonymous sources talking to Reuters. The news comes roughly a month after another report from the outlet suggesting that the wearables maker had brought on investment firm Qatalyst Partners to explore a potential sale, in which Alphabet was name dropped as a potential...
It may have been easy to miss, given the excitement of the quarter’s IPOs, but the third quarter of 2019 was actually a light one for digital health mergers and acquisitions, with just 10 deals — compared to 17 in Q1 and 12 in Q2.
As usual, we’ve ordered acquisitions by price first, then chronologically for the unknown terms — which is most of them. It’s worth noting that the quarter also saw...
Shortly after acquiring telemedicine company HeyDoctor, GoodRx, a digital cost transparency tool for medication, announced it is launching its own virtual care platform dubbed GoodRx Care, powered by HeyDoctor.
The company is positioning the new platform as a primary care tool that will allow patients to see a board-certified clinician on the cheap — stating that “most visits” are about $20. Its...
Reuters reported on Friday that Fitbit is weighing a sale of its business. While nothing is set in stone, the fitness wearables and health services company is said to have brought on investment firm Qatalyst Partners to explore its options, with the latter pushing for Alphabet or private equity firms as potential buyers.
The report pins Fitbit’s new mindset on middling smartwatch success, which...
Heal, maker of an app for booking and processing device-driven physician house calls, announced today that it has acquired New York City-based Doctors on Call, a roughly 50-year-old provider of house call services for elderly patients.
The acquisition allows Heal to expand its services — previously limited to the Atlanta, California and Northern Virginia/Washington D.C. areas — into the New York...
TrialCard, a company that works with pharma manufacturers to link patients to medications and services, announced last week that it is set to acquire Mango Health, maker of a gamified patient engagement tool and medication adherence platform, for an undisclosed amount.
As part of the deal, TrialCard will acquire Mango's app, which lets patients track their medication and adherence. It also has a...
OptimizeRx, a software company that enables digital health messaging between pharmas and providers, has announced plans to acquire RMDY Health, a SaaS platform designed for digital therapeutics, within the next 30 days.
According to the notice, RMDY shareholders will be receiving $8 million in cash and another $8 million in equity upon the deal’s closure. OptimizeRx said that additional details...
